Across
- 4. Study assessing Dapa in HFmrEF and HFpEF
- 6. The target organ of Dexiglofozin action
- 8. One pill of Dexiglofozin can provide many ....
- 10. Largest CVOT to assess hHF reduction of Dapa in 1ry and 2ry prevention patients
- 14. Decreased pressure in the kidney as a benefit of Dexiglofozin
- 15. Type-1 diabetes treatment
- 16. The active ingredient of Dexiglofozin
Down
- 1. Document with the aim of guiding medical decisions
- 2. Excreted element in the urine with water and glucose by the effect of SGLT2i
- 3. Minimum eGFR to initiate Dexiglofozin
- 5. Degree of Dexiglofozin efficacy
- 7. Deterioration of kidney function
- 9. Pressure under which the heart fills
- 11. Inhibited process by metformin
- 12. Release of metformin in Dexiglofozin Plus
- 13. Excretion of albumin in urine